Additional information
| Active substance | Anastrozole |
|---|---|
| Active Half-Life | 2 days |
| Classification | Non-steroidal aromatase inhibitor |
| Dosage | 0.5-1 mg/day |
| Acne | No |
| Water Retention | No |
| HBR | No |
| Hepatotoxicity | No |
| Aromatization | No |
| Lab Test | Monitors estrogen levels and liver function |
| Also known as | Anastrol, Anastrozolo |
| WAREHOUSE | International Warehouse 1 |
| Blood pressure | Can cause changes in blood pressure, monitor regularly |
| Trade name | Arimidex |
| Storage conditions | Store at room temperature, away from moisture and heat |
| Chemical name | 2,2'-(5-(1H-1,2,4-triazol-1-ylmethyl)-1,3-phenylene)bis(2-methylpropanenitrile) |
| Formula | C17H19N5 |
| Substance class | Aromatase inhibitor |
| Main action | Inhibits enzyme aromatase, reducing estrogen production |
| Half-life | 46.8 hours |
| Dosage (medical) | 1 mg once daily |
| Dosage (sports) | Not officially recommended, varies widely, typically 0.5 mg to 1 mg every other day |
| Effects | Reduces estrogen levels, increases testosterone levels |
| Side effects | Hot flashes, joint stiffness or pain, weakness, sore throat, depression, nausea, and vomiting |
| Use in sports | Used to control estrogen levels and prevent gynecomastia in anabolic steroid users |
| Manufacturer | Zydus Pharma |
Reviews
There are no reviews yet.